Stoke therapeutics stock.
Seth Harrison owns over 23,131 units of Stoke Therapeutics stock worth over $1,502,839 and over the last 4 years he sold STOK stock worth over $15,056,711. In addition, he makes $525,048 as Independent Chairman of the Board at Stoke Therapeutics. Wallmine is a radically better financial terminal.
Structure Therapeutics started at outperform with $40 stock price target at BMO Capital. Feb. 28, 2023 at 9:46 a.m. ET by Tomi Kilgore.Discover historical prices for STOK stock on Yahoo Finance. View daily, weekly or monthly format back to when Stoke Therapeutics, Inc. stock was issued.For example, if you want to buy shares of Stoke Therapeutics, Inc., you could place a limit order to buy at $3.46 per share. If the price of Stoke Therapeutics, Inc. drops to $3.46 or less, your order will be executed. Your order will not be executed if the price never drops to $3.46. Limit orders can be helpful for investors who want to be ...Stoke Therapeutics Stock Forecast. ... According to 7 stock analysts, the average 12-month stock price forecast for STOK stock stock is $21, which predicts an ...
Find the latest Context Therapeutics Inc. (CNTX) stock quote, history, news and other vital information to help you with your stock trading and investing.Overview Stock Screener Earnings Calendar Sectors Nasdaq | STOK U.S.: Nasdaq Stoke Therapeutics Inc. Watch NEW Set a price target alert After Hours Last …Overview News Stoke Therapeutics Inc. No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) N/A EPS (TTM) $-2.54 Market Cap $180.72 M Shares …
Find the latest Tenaya Therapeutics, Inc. (TNYA) stock quote, history, news and other vital information to help you with your stock trading and investing.Share STOKE THERAPEUTICS INC COM USD0.0001 ; Currency. US Dollar ; Sector. - ; Sector. - ; Share type. Stock ; ISIN. US86150R1077.
Stoke Therapeutics Stock Price Chart Technical Analysis: Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and STOK is experiencing slight selling pressure.Find the latest Werewolf Therapeutics, Inc. (HOWL) stock quote, history, news and other vital information to help you with your stock trading and investing.STOKE THERAPEUTICS, INC. (Name of Subject Company (Issuer) and Filing Person (Offeror)) Options to Purchase Common Stock, Par Value $0.0001 Per Share (Title of Class of Securities) 86150R107 (CUSIP Number of Class of Securities) Edward M. Kaye, M.D. Chief Executive Officer . Stoke Therapeutics, Inc. 45 Wiggins Avenue . Bedford, Massachusetts 01730Upcoming events on Stoke Therapeutics, Inc. 2023-12-02 12:00 pm American Epilepsy Society Meeting - Poster No:1.276
Cookie Duration Description; _ga: 2 years: The _ga cookie, installed by Google Analytics, calculates visitor, session and campaign data and also keeps track of site usage for the site's analytics report.
Stock Quote. Change. Volume. Today's Open. Previous Close. Today's High. Today's Low. 52 Week High. 52 Week Low.
Company Description. Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary targeted augmentation of nuclear gene output to develop antisense oligonucleotides to selectively restore protein levels.Dec 1, 2023 · STOK Earnings Date and Information. Stoke Therapeutics last posted its quarterly earnings data on November 7th, 2023. The reported ($0.55) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.65) by $0.10. The business earned $3.31 million during the quarter, compared to analyst estimates of $3.83 million. Dec 1, 2023 · Stoke Media & Investor Contacts: Dawn Kalmar Chief Communications Officer [email protected] 781-303-8302 Eric Rojas Vice President, Investor Relations [email protected] 617-312-2754 Source: Stoke Therapeutics, Inc. 34.02%. Get the latest Stoke Therapeutics Inc (STOK) real-time quote, historical performance, charts, and other financial information to help you make more informed …Stoke Therapeutics, Inc. Common Stock, Preferred Stock, Debt Securities, Warrants, Subscription Rights and Units . From time to time, we may offer up to $400,000,000 ... STOKE THERAPEUTICS, INC. (Name of Subject Company (Issuer) and Filing Person (Offeror)) Options to Purchase Common Stock, Par Value $0.0001 Per Share (Title of Class of Securities) 86150R107 (CUSIP Number of Class of Securities) Edward M. Kaye, M.D. Chief Executive Officer . Stoke Therapeutics, Inc.
BEDFORD, Mass., September 20, 2023--Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to addressing the underlying cause of severe diseases by upregulating protein ...Find the latest Ionis Pharmaceuticals, Inc. (IONS) stock quote, history, news and other vital information to help you with your stock trading and investing.4 equities research analysts have issued 1-year target prices for Viracta Therapeutics' shares. Their VIRX share price targets range from $5.00 to $16.00. On average, they predict the company's share price to reach $9.25 in the next twelve months. This suggests a possible upside of 1,645.3% from the stock's current price.Moderna, Inc. (NASDAQ:MRNA) issued its earnings results on Thursday, November, 2nd. The company reported ($1.39) EPS for the quarter, beating the consensus estimate of ($2.01) by $0.62. The business earned $1.83 billion during the quarter, compared to analysts' expectations of $1.37 billion.In today’s fast-paced world, finding activities that provide relaxation and a sense of accomplishment is more important than ever. One such activity that has gained popularity in recent years is crafting and building.Stoke Therapeutics, Inc. is a biotechnology company, which engages in the research and development of treatments for genetic diseases. It offers a wide range of relevant tissues including the central nervous system, eye, kidney, and liver. The company was founded by Isabel Aznarez and Adrian R. Krainer in June 2014 and is headquartered in ...
Stoke Therapeutics (Nasdaq: STOK), is a biotechnology company dedicated to addressing the underlying cause of severe diseases by upregulating protein …
Find the latest Ionis Pharmaceuticals, Inc. (IONS) stock quote, history, news and other vital information to help you with your stock trading and investing. Stoke Therapeutics Presents Data From Multiple Studies of Children and Adolescents With Dravet Syndrome at the American Epilepsy Society (AES) 2023 …Company profile page for Stoke Therapeutics Inc including stock price, company news, press releases, executives, board members, and contact information Stoke Therapeutics (STOK – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Thomas Shrader from BTIG remains neutral on the stock and ...Share STOKE THERAPEUTICS INC COM USD0.0001 ; Currency. US Dollar ; Sector. - ; Sector. - ; Share type. Stock ; ISIN. US86150R1077.Find the latest Akero Therapeutics, Inc. (AKRO) stock quote, history, news and other vital information to help you with your stock trading and investing.Stoke Therapeutics Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. ... Stoke Therapeutics, Inc. (Nasdaq: …Find the latest Tango Therapeutics, Inc. (TNGX) stock quote, history, news and other vital information to help you with your stock trading and investing.Find the latest Coya Therapeutics, Inc. (COYA) stock quote, history, news and other vital information to help you with your stock trading and investing.Find the latest Gain Therapeutics, Inc. (GANX) stock quote, history, news and other vital information to help you with your stock trading and investing.
Nov 21, 2023 · For example, if you want to buy shares of Stoke Therapeutics, Inc., you could place a limit order to buy at $3.46 per share. If the price of Stoke Therapeutics, Inc. drops to $3.46 or less, your order will be executed. Your order will not be executed if the price never drops to $3.46. Limit orders can be helpful for investors who want to be ...
BEDFORD, Mass., September 20, 2023--Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to addressing the underlying cause of severe diseases by upregulating protein ...
Stoke Cares. Stoke employees care about building community both internally and externally. Company-sponsored activities include company gatherings and celebrations, efforts to give back to local communities, and opportunities to share interests and explore new pursuits — all within a respectful, friendly and diverse culture. Aug 7, 2023 · Stoke Therapeutics Inc Stock Price History. Stoke Therapeutics Inc’s price is currently down 11.9% so far this month. During the month of August, Stoke Therapeutics Inc’s stock price has reached a high of $6.58 and a low of $5.40. Over the last year, Stoke Therapeutics Inc has hit prices as high as $22.87 and as low as $5.79. Year to date ... Stoke Therapeutics, Inc. (STOK) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.Nov 29, 2023 · Stoke Therapeutics to Present Data from the Company's Dravet Syndrome Clinical Program at the American Epilepsy Society 2023 Annual Meeting. BEDFORD, Mass.--(BUSINESS WIRE)--Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to addressing the underlying cause of severe diseases by upregulating protein expression wit... Stoke Therapeutics Stock Price Chart Technical Analysis: The current trend is moderately bearish and STOK is experiencing selling pressure, which indicates risk of future bearish movement.Stoke Therapeutics (Nasdaq: STOK), is a biotechnology company dedicated to addressing the underlying cause of severe diseases. The company is pursuing an entirely new approach to treating severe ...Stoke Therapeutics Stock Price Chart Technical Analysis: Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and STOK is experiencing slight selling pressure.Stoke Therapeutics Stock Forecast. ... According to 7 stock analysts, the average 12-month stock price forecast for STOK stock stock is $21, which predicts an ...Stoke Therapeutics Inc’s ( STOK) price is currently down 10.24% so far this month. During the month of March, Stoke Therapeutics Inc’s stock price has reached a high of $9.99 and a low of $7.22. Over the last year, Stoke Therapeutics Inc has hit prices as high as $24.97 and as low as $6.88. Year to date, Stoke Therapeutics Inc’s stock is ...Nov 8, 2023 · Stoke Therapeutics Inc (STOK) has experienced a 27.30% rise in stock performance for the past week, with a 28.31% rise in the past month, and a -13.08% drop in the past quarter. The volatility ratio for the week is 8.16%, and the volatility levels for the past 30 days are at 6.66% for STOK. The simple moving average for the past 20 days is 25. ... Nowadays finding high-quality stock photos for personal or commercial use is very simple. You just need to search the photo using a few descriptive words and let Google do the rest of the work.Stoke Therapeutics (Nasdaq: STOK), is a biotechnology company dedicated to addressing the underlying cause of severe diseases by upregulating protein expression with RNA-based medicines.
Stoke Therapeutics, Inc. (NASDAQ:STOK) released its earnings results on Tuesday, November, 7th. The company reported ($0.55) earnings per share (EPS) for …11 Nov 2023 ... Since July 2023, shares of Stoke's common stock have declined in value from a trading price of over $10.00 per share to a current trading price ...Find the latest Tenaya Therapeutics, Inc. (TNYA) stock quote, history, news and other vital information to help you with your stock trading and investing.Instagram:https://instagram. best stock advisor for swing tradingfreight wave newsbuy chain link cryptobest robinhood stocks 2023 Find the latest Intellia Therapeutics, Inc. (NTLA) stock quote, history, news and other vital information to help you with your stock trading and investing. n.b.k.ford stock dividens The estimated Net Worth of Stephen J Tulipano is at least $1.22 Million dollars as of 2 June 2022. Mr. Tulipano owns over 11,160 units of Stoke Therapeutics stock worth over $44,696 and over the last 9 years he sold STOK stock worth over $0. In addition, he makes $1,176,400 as Chief Financial Officer at Stoke Therapeutics. costco stock dividends Nov 7, 2023 · Stoke Therapeutics (Nasdaq: STOK), is a biotechnology company dedicated to addressing the underlying cause of severe diseases by upregulating protein expression with RNA-based medicines. Using the company’s proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach Stoke is developing antisense oligonucleotides (ASOs) to ... Non-numerical data is data which is observed, not measured. Non-numerical data deals with descriptions like the smell of a cookie, the feel of bed linens and the type of brush stokes on a painting.Find the latest Inovio Pharmaceuticals, Inc. (INO) stock quote, history, news and other vital information to help you with your stock trading and investing.